Bioquell Plc is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company's operating segment is Bio-decontamination (BIO). The Company offers various products, which include Healthcare products, such as Healthcare HP Vapor Services, Healthcare HP Vapor Generators, Healthcare Patient Rooms, Healthcare Pharmacy Workstation, Healthcare Consumables/Accessories and Healthcare Archived Products; Life Science products, such as Life Sciences Aseptic Workstation, Life Sciences HP Vapor Services, Life Sciences Materials Transfer, Life Sciences HP Vapor Generators, Life Sciences Consumables/Accessories and Archived Products, and Defense products, such as Defense CBRN Filtration, Controls, Defense Pre-filtration, and Defense Consumables and Spares.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: N/A
- Symbol: LON:BQE
- CUSIP: N/A
- Web: www.bioquellplc.com
- Market Cap: £43.95 million
- Outstanding Shares: 22,004,000
- 50 Day Moving Avg: GBX 169.23
- 200 Day Moving Avg: GBX 149.82
- 52 Week Range: GBX 125.60 - GBX 199.75
Sales & Book Value:
- Trailing P/E Ratio: 166.46
- P/E Growth: 0.00
- Annual Revenue: £26.49 million
- Price / Sales: 1.66
- Book Value: GBX 1.08 per share
- Price / Book: 1.85
- EBIDTA: £3.28 million
- Net Margins: 0.46%
- Return on Equity: 0.54%
- Return on Assets: 0.43%
- Average Volume: 32,400 shs.
Frequently Asked Questions for Bioquell plc (LON:BQE)
What is Bioquell plc's stock symbol?
Bioquell plc trades on the London Stock Exchange (LON) under the ticker symbol "BQE."
Who are some of Bioquell plc's key competitors?
Some companies that are related to Bioquell plc include T2 Biosystems (TTOO), Tandem Diabetes Care (TNDM), Capnia (SLNO), Surgical Innovations Group Plc (SUN), Alliqua BioMedical (ALQA), Cytori Therapeutics (CYTX), Lombard Medical (EVAR), InspireMD (NSPR), NeuroMetrix (NURO), CareFusion (CFN), Covidien Ltd (COV), CRH Medical Corp (CRHM), Great Basin Scientific (GBSN) and LDR Holding Corp (LDRH).
Who are Bioquell plc's key executives?
Bioquell plc's management team includes the folowing people:
- Nicholas M. T. Adams, Chief Executive, Executive Director
- Michael R. D. Roller, Group Finance Director, Executive Director
- Georgina Pope, Company Secretary
- Ian Roy Johnson, Non-Executive Chairman of the Board
- Anthony Rhys Bourne, Independent Non-Executive Director
- Ian Carruthers OBE, Independent Non-Executive Director
- Simon John Constantine, Independent Non-Executive Director
- Christopher Harwood Bernard Mills, Independent Non-Executive Director
How do I buy Bioquell plc stock?
Shares of Bioquell plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Bioquell plc's stock price today?
MarketBeat Community Rating for Bioquell plc (LON BQE)MarketBeat's community ratings are surveys of what our community members think about Bioquell plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Bioquell plc stock can currently be purchased for approximately GBX 199.75.
Consensus Ratings for Bioquell plc (LON:BQE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Bioquell plc (LON:BQE)
(Data available from 7/27/2015 forward)
|3/7/2017||N+1 Singer||Reiterated Rating||Corporate|
Earnings History for Bioquell plc (LON:BQE)Earnings History by Quarter for Bioquell plc (LON BQE)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Bioquell plc (LON:BQE)
Current Year EPS Consensus Estimate: $6.90 EPS
Dividend History by Quarter for Bioquell plc (LON BQE)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Bioquell plc (LON:BQE)Insider Trades by Quarter for Bioquell plc (LON:BQE)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/17/2017||Michael R D Roller||Insider||Buy||13,381||GBX 159||£21,275.79|
|4/5/2017||Michael R D Roller||Insider||Buy||19,000||GBX 148||£28,120|
Headline Trends for Bioquell plc (LON:BQE)
Latest Headlines for Bioquell plc (LON:BQE)
Bioquell plc (BQE) Chart for Thursday, July, 27, 2017